177 related articles for article (PubMed ID: 37943484)
1. Exploration of molecular markers related to chemotherapy efficacy of hepatoid adenocarcinoma of the stomach.
Wei J; Ji K; Zhang Y; Zhang J; Wu X; Ji X; Zhou K; Yang X; Lu H; Wang A; Bu Z
Cell Oncol (Dordr); 2024 Apr; 47(2):677-693. PubMed ID: 37943484
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive Analysis of Genomic Alterations in Hepatoid Adenocarcinoma of the Stomach and Identification of Clinically Actionable Alterations.
Zhao R; Li H; Ge W; Zhu X; Zhu L; Wan X; Wang G; Pan H; Lu J; Han W
Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36010842
[TBL] [Abstract][Full Text] [Related]
3. [Exploration of potential beneficial people of neoadjuvant chemotherapy based on clinical staging in gastric cancer: a single center retrospective study].
Wang YK; Wang YC; Shan F; Tang L; Li ZY; Ji JF
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Feb; 23(2):152-157. PubMed ID: 32074795
[No Abstract] [Full Text] [Related]
4. Integrated clinicopathological and immunohistochemical analysis of gastric adenocarcinoma with hepatoid differentiation: an exploration of histogenesis, molecular characteristics, and prognostic markers.
He F; Fu Y; Sun Q; Geng P; Zheng Z; Pu X; Shi J; Fan X
Hum Pathol; 2021 Sep; 115():37-46. PubMed ID: 33636206
[TBL] [Abstract][Full Text] [Related]
5. The Value of Perioperative Chemotherapy for Patients With Hepatoid Adenocarcinoma of the Stomach Undergoing Radical Gastrectomy.
Zhou K; Wang A; Wei J; Ji K; Li Z; Ji X; Fu T; Jia Z; Wu X; Zhang J; Bu Z
Front Oncol; 2021; 11():789104. PubMed ID: 35083146
[TBL] [Abstract][Full Text] [Related]
6. Integrative analysis reveals a clinicogenomic landscape associated with liver metastasis and poor prognosis in hepatoid adenocarcinoma of the stomach.
Jiang J; Ding Y; Lu J; Chen Y; Chen Y; Zhao W; Chen W; Kong M; Li C; Teng X; Zhou Q; Xu N; Zhou D; Zhou Z; Wang H; Teng L
Int J Biol Sci; 2022; 18(14):5554-5574. PubMed ID: 36147475
[TBL] [Abstract][Full Text] [Related]
7. Next-generation sequencing analysis for gastric adenocarcinoma with enteroblastic differentiation: emphasis on the relationship with hepatoid adenocarcinoma.
Akazawa Y; Saito T; Hayashi T; Yanai Y; Tsuyama S; Akaike K; Suehara Y; Takahashi F; Takamochi K; Ueyama H; Murakami T; Watanabe S; Nagahara A; Yao T
Hum Pathol; 2018 Aug; 78():79-88. PubMed ID: 29751042
[TBL] [Abstract][Full Text] [Related]
8. [Clinical characteristics, diagnosis and treatment of hepatoid adenocarcinoma of the stomach].
Yang CK; Zhao WJ; Dai QB; Zhang HH; Zheng W
Zhonghua Wei Chang Wai Ke Za Zhi; 2007 May; 10(3):245-8. PubMed ID: 17520383
[TBL] [Abstract][Full Text] [Related]
9. Characterization of genomic alterations and neoantigens and analysis of immune infiltration identified therapeutic and prognostic biomarkers in adenocarcinoma at the gastroesophageal junction.
Lao Y; Wang Y; Yang J; Liu T; Ma Y; Luo Y; Sun Y; Li K; Zhao X; Niu X; Xi Y; Zhong C
Front Oncol; 2022; 12():941868. PubMed ID: 36439494
[TBL] [Abstract][Full Text] [Related]
10. Multiplex profiling of peritoneal metastases from gastric adenocarcinoma identified novel targets and molecular subtypes that predict treatment response.
Wang R; Song S; Harada K; Ghazanfari Amlashi F; Badgwell B; Pizzi MP; Xu Y; Zhao W; Dong X; Jin J; Wang Y; Scott A; Ma L; Huo L; Vicente D; Blum Murphy M; Shanbhag N; Tatlonghari G; Thomas I; Rogers J; Kobayashi M; Vykoukal J; Estrella JS; Roy-Chowdhuri S; Han G; Zhang S; Mao X; Song X; Zhang J; Gu J; Johnson RL; Calin GA; Peng G; Lee JS; Hanash SM; Futreal A; Wang Z; Wang L; Ajani JA
Gut; 2020 Jan; 69(1):18-31. PubMed ID: 31171626
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive analyses using next-generation sequencing and immunohistochemistry enable precise treatment in advanced gastric cancer.
Kuboki Y; Yamashita S; Niwa T; Ushijima T; Nagatsuma A; Kuwata T; Yoshino T; Doi T; Ochiai A; Ohtsu A
Ann Oncol; 2016 Jan; 27(1):127-33. PubMed ID: 26489445
[TBL] [Abstract][Full Text] [Related]
12. Genomics of
Lipsyc-Sharf M; Jain E; Collins LC; Rosenberg SM; Ruddy KJ; Tamimi RM; Schapira L; Come SE; Peppercorn JM; Borges VF; Warner E; Snow C; Krop IE; Kim D; Weiss J; Zanudo JGT; Partridge AH; Wagle N; Waks AG
JCO Precis Oncol; 2023 Jun; 7():e2300076. PubMed ID: 37364233
[TBL] [Abstract][Full Text] [Related]
13. Hepatoid adenocarcinoma of the stomach: a unique subgroup with distinct clinicopathological and molecular features.
Wang Y; Sun L; Li Z; Gao J; Ge S; Zhang C; Yuan J; Wang X; Li J; Lu Z; Gong J; Lu M; Zhou J; Peng Z; Shen L; Zhang X
Gastric Cancer; 2019 Nov; 22(6):1183-1192. PubMed ID: 30989433
[TBL] [Abstract][Full Text] [Related]
14. Circulating Tumor DNA Analysis Detects
Jogo T; Nakamura Y; Shitara K; Bando H; Yasui H; Esaki T; Terazawa T; Satoh T; Shinozaki E; Nishina T; Sunakawa Y; Komatsu Y; Hara H; Oki E; Matsuhashi N; Ohta T; Kato T; Ohtsubo K; Kawakami T; Okano N; Yamamoto Y; Yamada T; Tsuji A; Odegaard JI; Taniguchi H; Doi T; Fujii S; Yoshino T
Clin Cancer Res; 2021 Oct; 27(20):5619-5627. PubMed ID: 34376535
[TBL] [Abstract][Full Text] [Related]
15. Hepatoid adenocarcinoma of the stomach - a different histology for not so different gastric adenocarcinoma: a case report.
Gálvez-Muñoz E; Gallego-Plazas J; Gonzalez-Orozco V; Menarguez-Pina F; Ruiz-Maciá JA; Morcillo MA
Int Semin Surg Oncol; 2009 Aug; 6():13. PubMed ID: 19674468
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological features and genomic profiles of hepatoid adenocarcinoma of the lung: Report of four cases.
Sun H; Li X; Zhang J; Liu Y
Pathol Res Pract; 2022 Jan; 229():153652. PubMed ID: 34826742
[TBL] [Abstract][Full Text] [Related]
17.
Klempner SJ; Madison R; Pujara V; Ross JS; Miller VA; Ali SM; Schrock AB; Kim ST; Maron SB; Dayyani F; Catenacci DVT; Lee J; Chao J
Oncologist; 2019 Nov; 24(11):1462-1468. PubMed ID: 31249137
[TBL] [Abstract][Full Text] [Related]
18. Association of recurrent APOBEC3B alterations with the prognosis of gastric-type cervical adenocarcinoma.
Liao X; Xia X; Su W; Yan H; Ma Y; Xu L; Luo H; Liu W; Yin D; Zhang WH; Chen HN; Deng Y; Ren Z; Yu Z; Liao F; Chen K; Cao M; Zhang Y; Zhang W; Wang W; Zhao JN; Xu H; Shu Y
Gynecol Oncol; 2022 Apr; 165(1):105-113. PubMed ID: 35151492
[TBL] [Abstract][Full Text] [Related]
19. [Neoadjuvant chemoradiotherapy combined with surgery versus direct surgery in the treatment of Siewert type II and III adenocarcinomas of the esophagogastric junction: long-term prognostic analysis of a prospective randomized controlled trial].
Tian Y; Wang Q; Wang J; Qiao XY; Zhang J; Lin YC; Li Y; Fan LQ; Yang PG; Zhao Q
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):128-137. PubMed ID: 33508918
[No Abstract] [Full Text] [Related]
20. Impact of genomic alterations on lapatinib treatment outcome and cell-free genomic landscape during HER2 therapy in HER2+ gastric cancer patients.
Kim ST; Banks KC; Pectasides E; Kim SY; Kim K; Lanman RB; Talasaz A; An J; Choi MG; Lee JH; Sohn TS; Bae JM; Kim S; Park SH; Park JO; Park YS; Lim HY; Kim NKD; Park W; Lee H; Bass AJ; Kim K; Kang WK; Lee J
Ann Oncol; 2018 Apr; 29(4):1037-1048. PubMed ID: 29409051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
